Cargando…

Mathematical modeling in cancer nanomedicine: a review

Cancer continues to be among the leading healthcare problems worldwide, and efforts continue not just to find better drugs, but also better drug delivery methods. The need for delivering cytotoxic agents selectively to cancerous cells, for improved safety and efficacy, has triggered the application...

Descripción completa

Detalles Bibliográficos
Autores principales: Dogra, Prashant, Butner, Joseph D., Chuang, Yao-li, Caserta, Sergio, Goel, Shreya, Brinker, C. Jeffrey, Cristini, Vittorio, Wang, Zhihui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449316/
https://www.ncbi.nlm.nih.gov/pubmed/30949850
http://dx.doi.org/10.1007/s10544-019-0380-2
_version_ 1783408817576345600
author Dogra, Prashant
Butner, Joseph D.
Chuang, Yao-li
Caserta, Sergio
Goel, Shreya
Brinker, C. Jeffrey
Cristini, Vittorio
Wang, Zhihui
author_facet Dogra, Prashant
Butner, Joseph D.
Chuang, Yao-li
Caserta, Sergio
Goel, Shreya
Brinker, C. Jeffrey
Cristini, Vittorio
Wang, Zhihui
author_sort Dogra, Prashant
collection PubMed
description Cancer continues to be among the leading healthcare problems worldwide, and efforts continue not just to find better drugs, but also better drug delivery methods. The need for delivering cytotoxic agents selectively to cancerous cells, for improved safety and efficacy, has triggered the application of nanotechnology in medicine. This effort has provided drug delivery systems that can potentially revolutionize cancer treatment. Nanocarriers, due to their capacity for targeted drug delivery, can shift the balance of cytotoxicity from healthy to cancerous cells. The field of cancer nanomedicine has made significant progress, but challenges remain that impede its clinical translation. Several biophysical barriers to the transport of nanocarriers to the tumor exist, and a much deeper understanding of nano-bio interactions is necessary to change the status quo. Mathematical modeling has been instrumental in improving our understanding of the physicochemical and physiological underpinnings of nanomaterial behavior in biological systems. Here, we present a comprehensive review of literature on mathematical modeling works that have been and are being employed towards a better understanding of nano-bio interactions for improved tumor delivery efficacy.
format Online
Article
Text
id pubmed-6449316
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-64493162019-04-17 Mathematical modeling in cancer nanomedicine: a review Dogra, Prashant Butner, Joseph D. Chuang, Yao-li Caserta, Sergio Goel, Shreya Brinker, C. Jeffrey Cristini, Vittorio Wang, Zhihui Biomed Microdevices Article Cancer continues to be among the leading healthcare problems worldwide, and efforts continue not just to find better drugs, but also better drug delivery methods. The need for delivering cytotoxic agents selectively to cancerous cells, for improved safety and efficacy, has triggered the application of nanotechnology in medicine. This effort has provided drug delivery systems that can potentially revolutionize cancer treatment. Nanocarriers, due to their capacity for targeted drug delivery, can shift the balance of cytotoxicity from healthy to cancerous cells. The field of cancer nanomedicine has made significant progress, but challenges remain that impede its clinical translation. Several biophysical barriers to the transport of nanocarriers to the tumor exist, and a much deeper understanding of nano-bio interactions is necessary to change the status quo. Mathematical modeling has been instrumental in improving our understanding of the physicochemical and physiological underpinnings of nanomaterial behavior in biological systems. Here, we present a comprehensive review of literature on mathematical modeling works that have been and are being employed towards a better understanding of nano-bio interactions for improved tumor delivery efficacy. Springer US 2019-04-04 2019 /pmc/articles/PMC6449316/ /pubmed/30949850 http://dx.doi.org/10.1007/s10544-019-0380-2 Text en © The Author(s) 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Article
Dogra, Prashant
Butner, Joseph D.
Chuang, Yao-li
Caserta, Sergio
Goel, Shreya
Brinker, C. Jeffrey
Cristini, Vittorio
Wang, Zhihui
Mathematical modeling in cancer nanomedicine: a review
title Mathematical modeling in cancer nanomedicine: a review
title_full Mathematical modeling in cancer nanomedicine: a review
title_fullStr Mathematical modeling in cancer nanomedicine: a review
title_full_unstemmed Mathematical modeling in cancer nanomedicine: a review
title_short Mathematical modeling in cancer nanomedicine: a review
title_sort mathematical modeling in cancer nanomedicine: a review
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449316/
https://www.ncbi.nlm.nih.gov/pubmed/30949850
http://dx.doi.org/10.1007/s10544-019-0380-2
work_keys_str_mv AT dograprashant mathematicalmodelingincancernanomedicineareview
AT butnerjosephd mathematicalmodelingincancernanomedicineareview
AT chuangyaoli mathematicalmodelingincancernanomedicineareview
AT casertasergio mathematicalmodelingincancernanomedicineareview
AT goelshreya mathematicalmodelingincancernanomedicineareview
AT brinkercjeffrey mathematicalmodelingincancernanomedicineareview
AT cristinivittorio mathematicalmodelingincancernanomedicineareview
AT wangzhihui mathematicalmodelingincancernanomedicineareview